Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Daily News

AHA Statement Zeroes In On Sleep Health

L.A. McKeown

April 17, 2025

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy

L.A. McKeown

October 10, 2023

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

Advertisement

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

AHA Statement Zeroes In On Sleep Health

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

Kidney Events High in Older Patients After HF Hospitalization

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

AHA Selects 2023’s Leading Cardiovascular Research

FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Top Heart Failure News of 2022

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Guideline-Directed Therapies Underused in Frail HF Patients

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content